1. Home
  2. PFSA vs ADXN Comparison

PFSA vs ADXN Comparison

Compare PFSA & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFSA

Profusa Inc.

N/A

Current Price

$0.19

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

HOLD

Current Price

$8.23

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFSA
ADXN
Founded
2009
2002
Country
United States
Switzerland
Employees
N/A
2
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
11.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PFSA
ADXN
Price
$0.19
$8.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.8M
8.1K
Earning Date
11-19-2025
12-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$198,824.00
Revenue This Year
N/A
$86.57
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
122.22
N/A
52 Week Low
$0.12
$6.51
52 Week High
$12.76
$12.05

Technical Indicators

Market Signals
Indicator
PFSA
ADXN
Relative Strength Index (RSI) N/A 48.83
Support Level N/A $7.59
Resistance Level N/A $8.99
Average True Range (ATR) 0.00 0.52
MACD 0.00 0.05
Stochastic Oscillator 0.00 50.97

Price Performance

Historical Comparison
PFSA
ADXN

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: